3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
1
Solid Tumor
1
Hepatitis B
1
Gallstones
1
Depression
1
Condylomata Acuminata
1
Carcinoma, Hepatocellular
1
Anxiety Disorders
1
Interventions
Fluorodeoxyglucose F18
7
Irinotecan
4
Fluorouracil
4
Cyclophosphamide
4
Bevacizumab
4
toripalimab
3
pembrolizumab
3
olaparib
3
Radiosurgery
3
Cisplatin
3
Capecitabine
3
vistusertib
2
tislelizumab
2
spartalizumab
2
fludarabine
2
atezolizumab
2
apatinib
2
Temozolomide
2
Technetium
2
Specimen Handling
2
Sirolimus
2
Radiotherapy
2
Proton Therapy
2
Paclitaxel
2
Leucovorin
2
Letrozole
2
Hydroxychloroquine
2
Everolimus
2
Drug Therapy
2
Docetaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Solid Tumor
×
Hepatitis B Vaccines
×
Clear all
NCT02877589
2016-08-24
HepScreen
CHU de Reims
Completed
450 enrolled